Member Info for Rahulrajas

Oil - we will certianly get a RNS about all the trial sites. Could be tomorrow or any day of this week.
As news trickles this will shoot up.
GLA

Interferon beta is produced by various cells including fibroblasts and macrophages, and has both antiviral and immune regulatory activities. Interferon beta increases the levels of 2,5-oligo-adenylate (2-5A) synthetase, an intracellular enzyme that is capable of degrading viral RNA. This activity may contribute to the antiviral and antiproliferative effects of interferon beta. Interferon beta has antiviral activity against herpes virus, human papillomavirus, hepatitis B, hepatitis C, and human immunodeficiency syndrome virus.

Agree Manifesto.
Yes probably funds from richer countries would pour in to help the ones in need.

GLA

Manifesto - that’s a very sad news.
SNG will be very expensive for poor countries to afford.

Warwiclad- have you researched SNG?
Read this
Synairgen's two-part second-phase trial, called SG015, has been designed to assess inhaled interferon beta in chronic obstructive pulmonary disease patients when they have a cold or flu infection.

The data being presented are from the first part of the study, in which patients were treated with inhaled beta when they did not have a cold or flu infection.

Synairgen said analysis of samples from the lung shows that treatment with interferon beta boosted the lungs' antiviral defences, increasing Synairgen's confidence in the likelihood of a positive outcome in the second part of the study in which inhaled interferon beta is being assessed when patients have a confirmed respiratory virus infection.

ShareSting - good analysis. Maybe Lansdowne Partners know this and that’s why they added 4.3 million share to make a total of 25 million shares.

Sharesting what do you mean The CEO Richard has confirmed. When & where?

Sharesting what do you mean The CEO Richard has confirmed. When & where?

Wow. All the large buys.

Thanks Lp.
Read this report and there was news within last few days that remdesivir Is not as effective as expected.

Agree.
Inhaled interferon beta 1a has worked in earlier trial and improves lung function.
THIS WILL BE SUCCESSFUL.
HOLD AND WAIT.

Gilead shares slip as a 2nd remdesivir COVID-19 trial halted in China
https://www.fiercebiotech.com/biotech/gilead-shares-slip-as-a-second-remdesivir-covid-19-trial-halted-china

This is a very resilient share and has bounced back and will go up.

Systemic interferons is injected whereas SNG interferon beta is inhaled.
Inhaled interferon works better.

I phoned them and they explained how they got 33.6%
And yes it leaves Leonard Licht

33.6% is total of Lansdowne Partners 16.7% + Link 14.3% + directors 2.6%

Maqsood7 you are right.
Earlier Lansdowne Partners shares 20,673,111
Today as per the RNS Lansdowne shares 24,958,825
So overall that is an INCREASE of 4.3 million
Lansdowne Partners must be super confident about SNG.

I’m sure we’ll get a trial update very soon. Maybe tomorrow.

Newbie - you might get luck to get the shares at 60. However if news comes out then you’ll miss out on the rise.
Best to hold and wait.

This share moves very fast. Any news or RNS - major holders/TR-1 and the price will zoom past the previous high.

GLA